Synovial Fibroblast 3.2: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis-diagnosed donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 2 of 2) - Dataset (ID:20235)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA1931 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 1 | IL-1B | 307.0 | 101 | |
RA1931 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 1 | IL-1B | 371.5 | 86 | |
N2586 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 1 | IL-1B | 367.5 | 74 | |
N2586 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 1 | IL-1B | 350.5 | 66 | |
RA1869 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | IL-1B | 417.0 | 70 | |
RA1869 | TNF-a | 100 | ng/mL | 1 | IL-1B | 428.5 | 78 | ||||
N2759 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | IL-1B | 422.0 | 71 | |
N2759 | TNF-a | 100 | ng/mL | 1 | IL-1B | 465.0 | 56 | ||||
RA1931 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | IL-1B | 440.5 | 58 | |
RA1931 | TNF-a | 100 | ng/mL | 1 | IL-1B | 449.0 | 71 | ||||
N2586 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | IL-1B | 433.5 | 62 | |
N2586 | TNF-a | 100 | ng/mL | 1 | IL-1B | 387.5 | 56 | ||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-1B | 12.0 | 69 | |
RA1869 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-1B | 19.5 | 82 | |
N2759 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-1B | 11.0 | 67 | |
N2759 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-1B | 27.0 | 65 | |
RA1931 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-1B | 13.5 | 72 | |
RA1931 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-1B | 22.0 | 62 | |
N2586 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-1B | 17.5 | 60 | |
N2586 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-1B | 41.0 | 69 | |
RA1869 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-1B | 74.0 | 79 | |
RA1869 | IL-1 alpha | 100 | ng/mL | 1 | IL-1B | 86.0 | 61 | ||||
N2759 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-1B | 87.5 | 50 | |
N2759 | IL-1 alpha | 100 | ng/mL | 1 | IL-1B | 93.0 | 54 | ||||
RA1931 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-1B | 76.0 | 46 |